DUBLIN, December 1, 2017 /PRNewswire/ -- The "Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy" report has been added to Research and Markets'...
from PR Newswire: //www.prnewswire.co.uk/news-releases/asia-pacific-149-billion-hemophilia-a-and-b-therapeutics-market-to-2023-661286053.html
No comments:
Post a Comment